SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jan 06, 2025 | Option Exercise | $3.15 | 50,000 | 157,500 | 260,346 | Jan 07, 2025, 06:24 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jan 06, 2025 | Sale | $11.10 | 50,000 | 555,065 | 210,346 | Jan 07, 2025, 06:24 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 02, 2024 | Option Exercise | $1.27 | 97,244 | 123,500 | 307,590 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 02, 2024 | Sale | $13.56 | 97,244 | 1,318,745 | 211,247 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 03, 2024 | Option Exercise | $2.60 | 87,984 | 229,010 | 298,330 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 03, 2024 | Sale | $13.26 | 87,984 | 1,166,897 | 210,346 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 04, 2024 | Option Exercise | $3.15 | 14,772 | 46,532 | 225,118 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Dec 04, 2024 | Sale | $13.75 | 14,772 | 203,109 | 210,346 | Dec 04, 2024, 09:40 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Sep 01, 2023 | Option Exercise | $1.27 | 100,000 | 127,000 | 310,346 | Sep 05, 2023, 08:04 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Sep 01, 2023 | Sale | $7.71 | 100,000 | 770,520 | 210,346 | Sep 05, 2023, 08:04 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 03, 2023 | Sale | $7.01 | 26,107 | 183,018 | 210,346 | Aug 07, 2023, 05:05 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 04, 2023 | Option Exercise | $1.27 | 18,897 | 23,999 | 229,243 | Aug 07, 2023, 05:05 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 04, 2023 | Sale | $7.06 | 18,897 | 133,471 | 210,346 | Aug 07, 2023, 05:05 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 03, 2023 | Option Exercise | $1.27 | 26,107 | 33,156 | 236,453 | Aug 07, 2023, 05:05 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 01, 2023 | Option Exercise | $1.27 | 18,715 | 23,768 | 229,061 | Aug 03, 2023, 06:03 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 01, 2023 | Sale | $7.19 | 18,715 | 134,576 | 210,346 | Aug 03, 2023, 06:03 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 02, 2023 | Option Exercise | $1.27 | 36,281 | 46,077 | 246,627 | Aug 03, 2023, 06:03 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Aug 02, 2023 | Sale | $7.09 | 36,281 | 257,265 | 210,346 | Aug 03, 2023, 06:03 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 07, 2023 | Option Exercise | $1.27 | 8,858 | 11,250 | 219,204 | Jul 07, 2023, 08:16 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 07, 2023 | Sale | $6.36 | 8,858 | 56,372 | 210,346 | Jul 07, 2023, 08:16 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 05, 2023 | Option Exercise | $1.27 | 31,112 | 39,512 | 241,458 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 05, 2023 | Sale | $6.41 | 31,112 | 199,552 | 210,346 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 06, 2023 | Option Exercise | $1.27 | 33,510 | 42,558 | 243,856 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 06, 2023 | Sale | $6.34 | 33,510 | 212,554 | 210,346 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 03, 2023 | Option Exercise | $1.27 | 26,520 | 33,680 | 236,866 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jul 03, 2023 | Sale | $6.72 | 26,520 | 178,347 | 210,346 | Jul 06, 2023, 08:55 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jun 01, 2023 | Sale | $6.80 | 73,059 | 496,801 | 210,346 | Jun 02, 2023, 07:48 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jun 02, 2023 | Option Exercise | $1.27 | 26,941 | 34,215 | 237,287 | Jun 02, 2023, 07:48 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jun 02, 2023 | Sale | $6.95 | 26,941 | 187,240 | 210,346 | Jun 02, 2023, 07:48 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Jun 01, 2023 | Option Exercise | $1.27 | 73,059 | 92,785 | 283,405 | Jun 02, 2023, 07:48 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | May 08, 2023 | Option Exercise | $1.27 | 57,100 | 72,517 | 267,446 | May 10, 2023, 04:53 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | May 08, 2023 | Sale | $6.16 | 57,100 | 351,736 | 210,346 | May 10, 2023, 04:53 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | May 09, 2023 | Option Exercise | $1.27 | 42,900 | 54,483 | 253,246 | May 10, 2023, 04:53 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | May 09, 2023 | Sale | $5.31 | 42,900 | 227,799 | 210,346 | May 10, 2023, 04:53 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | Nov 09, 2022 | Sale | $4.58 | 43,896 | 201,044 | 210,346 | May 10, 2023, 04:53 PM |
SBTX | | Silverback Therapeutics, Inc. | Shawver Laura | Chief Executive Officer | Aug 05, 2022 | Option Exercise | $1.27 | 78,740 | 100,000 | 254,242 | Aug 09, 2022, 04:38 PM |
THOR | | Synthorx, Inc. | Shawver Laura | President and CEO | Jan 23, 2020 | Option Exercise | $68.00 | 220,595 | 15,000,460 | 0 | Jan 24, 2020, 06:41 PM |
THOR | | Synthorx, Inc. | Shawver Laura | President and CEO | Jan 23, 2020 | Option Exercise | $68.00 | 25,000 | 1,700,000 | 0 | Jan 24, 2020, 06:41 PM |
THOR | | Synthorx, Inc. | Shawver Laura | President and CEO | Dec 30, 2019 | Option Exercise | $70.63 | 210,010 | 14,833,006 | 296,301 | Jan 02, 2020, 04:39 PM |
THOR | | Synthorx, Inc. | Shawver Laura | President and CEO | Dec 30, 2019 | Option Exercise | $4.02 | 379,453 | 1,525,319 | 506,311 | Jan 02, 2020, 04:39 PM |
THOR | | Synthorx, Inc. | Shawver Laura | President and CEO | Jan 24, 2019 | Option Exercise | $0.63 | 25,000 | 15,750 | 25,000 | Jan 25, 2019, 04:33 PM |